Guelph, ON
ZEN Graphene Solutions Ltd. (“ZEN” or the “Company”) (TSX-V: ZEN and OTC: ZENYF), a Canadian, nanotechnology company focused on next-gen healthcare solutions, announces that it has signed a definitive commercial agreement with Trebor Rx (Trebor) for the manufacturing of ZENGuard™-enhanced personal protective equipment. The agreement includes surgical masks, filters for Trebor’s patent pending Pro+ mask, nitrile gloves and other potential products.
Greg Fenton CEO commented: ’’After working closely with George Irwin and the Trebor team over the last year, we have developed an excellent working relationship and are eager to launch our first product together, the Trebor Rx surgical mask with ZENGuard™ technology delivering over 99.99% bacterial and viral filtration efficiency. This is a significant commercial success for both our organizations, but more importantly, it brings a new option to healthcare employees and others in higher risk settings that wish to significantly enhance the bacterial and viral filtration efficiency compared to a typical, disposable ASTM level 3 mask.’’
’’Trebor and Zen have worked hard to bring a game changing mask to market. The enhanced protection in our mask is just the beginning of an extensive line of anti-microbial protective equipment designed to keep front line healthcare workers safer. The Trebor/Zen relationship is an example of two Canadian companies working together to develop, produce, market and sell world class product on the world stage.We are excited to be part of this journey with Greg Fenton, Francis Dube and the Zen group. ’’ commented George Irwin of Trebor Rx.
About Zentek Ltd.
Zentek is an ISO 13485‑certified intellectual property development and commercialization company that builds and advances distinct brands in filtration, biosciences and critical minerals using graphene‑based nanomaterials and aptamer technologies.
Zentek's ZenGUARD™ production facility is located in Guelph, Ontario.
To find out more about Zentek, please visit www.zentek.com. A copy of this news release and other material documents in respect of the Company may be obtained on Zentek's SEDAR+ profile at www.sedarplus.ca.
Forward-Looking Statements
This news release contains forward‑looking statements. Since forward‑looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward‑looking statements. Such risks and uncertainties include, but are not limited to, operational risks in exploration, development and production; delays or changes in plans with respect to exploration or development projects or capital expenditures; the uncertainties involved in the discovery and delineation of mineral deposits, resources or reserves; the uncertainty of resource and reserve estimates and the ability to economically exploit resources and reserves; the uncertainty of estimates and projections in relation to production, costs and expenses; the uncertainty surrounding the ability of the Company to obtain all permits, consents or authorizations required for its operations and activities; market and regulatory risks; and health, safety and environmental risks. Although Zentek believes that the assumptions and factors used in preparing the forward‑looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward‑looking information, whether as a result of new information, future events or otherwise, other than as required by law. Further studies, financing, permits and approvals would be required before a production decision Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.